151 related articles for article (PubMed ID: 9825475)
1. Distribution of somatostatin receptors in normal and neoplastic human tissues: recent advances and potential relevance.
Reubi JC; Schaer JC; Markwalder R; Waser B; Horisberger U; Laissue J
Yale J Biol Med; 1997; 70(5-6):471-9. PubMed ID: 9825475
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system.
Ferone D; Boschetti M; Resmini E; Giusti M; Albanese V; Goglia U; Albertelli M; Vera L; Bianchi F; Minuto F
Ann N Y Acad Sci; 2006 Jun; 1069():129-44. PubMed ID: 16855140
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands.
Reubi JC; Waser B; Schaer JC; Laissue JA
Eur J Nucl Med; 2001 Jul; 28(7):836-46. PubMed ID: 11504080
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA
Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptors in the thymus.
Ferone D; van Hagen PM; Colao A; Annunziato L; Lamberts SW; Hofland LJ
Ann Med; 1999 Oct; 31 Suppl 2():28-33. PubMed ID: 10574152
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels.
Reubi JC; Schaer JC; Laissue JA; Waser B
Metabolism; 1996 Aug; 45(8 Suppl 1):39-41. PubMed ID: 8769377
[TBL] [Abstract][Full Text] [Related]
7. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.
Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F
J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin and other Peptide receptors as tools for tumor diagnosis and treatment.
Reubi JC
Neuroendocrinology; 2004; 80 Suppl 1():51-6. PubMed ID: 15477718
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of somatostatin receptor subtypes sst1 and sst2 in the rat retina.
Helboe L; Møller M
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2376-82. PubMed ID: 10476805
[TBL] [Abstract][Full Text] [Related]
10. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14).
Reubi JC; Wenger S; Schmuckli-Maurer J; Schaer JC; Gugger M
Clin Cancer Res; 2002 Apr; 8(4):1139-46. PubMed ID: 11948125
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin, cortistatin and their receptors in tumours.
Volante M; Rosas R; Allìa E; Granata R; Baragli A; Muccioli G; Papotti M
Mol Cell Endocrinol; 2008 May; 286(1-2):219-29. PubMed ID: 18248880
[TBL] [Abstract][Full Text] [Related]
12. Expression and localisation of somatostatin receptor subtypes sst1-sst5 in areas of the rat medulla oblongata involved in autonomic regulation.
Spary EJ; Maqbool A; Batten TF
J Chem Neuroanat; 2008 Jan; 35(1):49-66. PubMed ID: 17646081
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptors in the gastrointestinal tract in health and disease.
Reubi JC
Yale J Biol Med; 1992; 65(5):493-503; discussion 531-6. PubMed ID: 1340064
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptors in human prostate and prostate cancer.
Reubi JC; Waser B; Schaer JC; Markwalder R
J Clin Endocrinol Metab; 1995 Sep; 80(9):2806-14. PubMed ID: 7673428
[TBL] [Abstract][Full Text] [Related]
15. Comparison of somatostatin receptor expression in human gliomas and medulloblastomas.
Cervera P; Videau C; Viollet C; Petrucci C; Lacombe J; Winsky-Sommerer R; Csaba Z; Helboe L; Daumas-Duport C; Reubi JC; Epelbaum J
J Neuroendocrinol; 2002 Jun; 14(6):458-71. PubMed ID: 12047721
[TBL] [Abstract][Full Text] [Related]
16. Expression of somatostatin receptors in peritumoral veins of human tumors.
Denzler B; Reubi JC
Cancer; 1999 Jan; 85(1):188-98. PubMed ID: 9921992
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of somatostatin receptor subtypes in benign and malignant adrenal tumours.
Unger N; Serdiuk I; Sheu SY; Walz MK; Schulz S; Saeger W; Schmid KW; Mann K; Petersenn S
Clin Endocrinol (Oxf); 2008 Jun; 68(6):850-7. PubMed ID: 18031328
[TBL] [Abstract][Full Text] [Related]
18. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.
Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW
J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843
[TBL] [Abstract][Full Text] [Related]
19. Are somatostatin and cortistatin two siblings in regulating endocrine secretions? In vitro work ahead.
Gahete MD; Durán-Prado M; Luque RM; Martínez-Fuentes AJ; Vázquez-Martínez R; Malagón MM; Castaño JP
Mol Cell Endocrinol; 2008 May; 286(1-2):128-34. PubMed ID: 18215456
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin receptors in human endocrine tumors.
Reubi JC; Maurer R; von Werder K; Torhorst J; Klijn JG; Lamberts SW
Cancer Res; 1987 Jan; 47(2):551-8. PubMed ID: 3024822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
